ETFs
K
KNSA
Kiniksa Pharmaceuticals Internat…
79.03
+0.56+0.71%After Hours: 80.41 +1.38 +1.75%19:57 08/21 EDT
OPEN/PREV CLOSE78.28/78.47
TODAY RANGE78.01-79.93
VOL270.12K
MARKET CAP6.17B
52 WEEK RANGE32.89-82.94
AVG VOL (3M)755.81K
% TURNOVER0.35%
TURNOVER--
P/E (TTM)80.41
% RANGE2.45%
EPS(TTM)0.9828
P/E(FORWARD)62.62
P/B9.43
BVPS8.38
DIVIDEND--
P/S8.90
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.65B
SHARES OUTSTANDING78.02M
NEXT EARNINGS10/26-10/30
FREE FLOAT46.16M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·08/09 08:34
Does Raised 2026 Revenue Guidance Change The Bull Case For Kiniksa Pharmaceuticals International (KNSA)?
Simply Wall St·08/01 16:28
Kiniksa Pharmaceuticals International (KNSA) After Raised 2026 Guidance And Strong Q2 Results Looks Fully Valued
TipRanks·08/01 02:02
Insider Shake-Up at Kiniksa Pharmaceuticals Sparks Investor Buzz
Simply Wall St·07/30 20:18
Kiniksa Pharmaceuticals (KNSA) Stock Cools As Raised Guidance Meets ARCALYST Reliance
Dow Jones·07/30 18:53
Kiniksa Pharmaceuticals Is Maintained at Buy by Goldman Sachs
Dow Jones·07/29 18:40
Kiniksa Pharmaceuticals Is Maintained at Overweight by JP Morgan
Dow Jones·07/29 17:54
Kiniksa Pharmaceuticals Is Maintained at Buy by Canaccord Genuity
Same Industry